4.4 Article

Characterizing and measuring bias in sequence data

Journal

GENOME BIOLOGY
Volume 14, Issue 5, Pages -

Publisher

BMC
DOI: 10.1186/gb-2013-14-5-r51

Keywords

-

Funding

  1. Federal funds from the National Human Genome Research Institute
  2. National Institutes of Health
  3. Department of Health and Human Services [U54HG003067]
  4. Federal funds from the National Institute of Allergy and Infectious Diseases
  5. National Institutes of Health, Department of Health and Human Services [HHSN272200900018C]
  6. NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003474, U54HG003067] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Background: DNA sequencing technologies deviate from the ideal uniform distribution of reads. These biases impair scientific and medical applications. Accordingly, we have developed computational methods for discovering, describing and measuring bias. Results: We applied these methods to the Illumina, Ion Torrent, Pacific Biosciences and Complete Genomics sequencing platforms, using data from human and from a set of microbes with diverse base compositions. As in previous work, library construction conditions significantly influence sequencing bias. Pacific Biosciences coverage levels are the least biased, followed by Illumina, although all technologies exhibit error-rate biases in high- and low-GC regions and at long homopolymer runs. The GC-rich regions prone to low coverage include a number of human promoters, so we therefore catalog 1,000 that were exceptionally resistant to sequencing. Our results indicate that combining data from two technologies can reduce coverage bias if the biases in the component technologies are complementary and of similar magnitude. Analysis of Illumina data representing 120- fold coverage of a well-studied human sample reveals that 0.20% of the autosomal genome was covered at less than 10% of the genome-wide average. Excluding locations that were similar to known bias motifs or likely due to sample-reference variations left only 0.045% of the autosomal genome with unexplained poor coverage. Conclusions: The assays presented in this paper provide a comprehensive view of sequencing bias, which can be used to drive laboratory improvements and to monitor production processes. Development guided by these assays should result in improved genome assemblies and better coverage of biologically important loci.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available